CastleArk Alternatives’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-66,145	Closed	-$3.34M	–	88
2021 Q3	$3.34M	Buy	+66,145	New	+$3.34M	0.13%	158